Opportunity ID: 277556

General Information

Document Type: Grants Notice
Funding Opportunity Number: W81XWH-15-MBRP-BIRA
Funding Opportunity Title: DoD Military Burn Injuries Research Award
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Grant
Category of Funding Activity: Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards: 4
Assistance Listings: 12.420 — Military Medical Research and Development
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Jun 30, 2015
Last Updated Date:
Original Closing Date for Applications: Dec 03, 2015
Current Closing Date for Applications: Dec 03, 2015
Archive Date: Jan 02, 2016
Estimated Total Program Funding: $8,000,000
Award Ceiling: $0
Award Floor: $0

Eligibility

Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:

Additional Information

Agency Name: Dept. of the Army — USAMRAA
Description: The MBRP Burn Injuries Research Award is being offered for the first time in FY15. The FY15 MBRP Burn Injuries Research Award is focused on specific research topics related to the treatment of traumatic burn injuries that are relevant to military personnel. Awards funded by the Burn Injuries Research Award may not be used to support fundamental basic research. Basic research is defined as research directed toward greater knowledge or understanding of the
fundamental aspects of phenomena and of observable facts without specific applications towards process or products in mind.
The FY15 Burn Injuries Research Award is focused on applied research, defined as research that refines concepts and ideas into potential solutions to health and performance problems with a view toward evaluating technical feasibility; it includes studies and investigations leading to candidate solutions in preparation for initial human testing.
Presentation of preliminary data is required. Inclusion of preliminary and/or published data relevant to the research question is required. In addition, investigators must demonstrate logical reasoning. To be competitive, the application must include a sound scientific rationale and a well-formulated, testable hypothesis established through a critical review and analysis of the literature. Clinical trials are allowed. Applications for promising pharmaceutical or biologic candidates and medical devices and technologies may be selected for initial safety and efficacy testing in small scale human clinical trials. A clinical trial is defined as a prospective accrual of human subjects where an intervention (e.g., device, drug, biologic, surgical procedure, rehabilitative modality, behavioral intervention or other) is tested on a human subject for a measurable outcome with respect to exploratory information, safety, effectiveness, and/or efficacy. This outcome represents a direct effect on the human subject of that intervention or interaction.
The term “human subjects” is used in this Program Announcement/Funding Opportunity to refer to individuals who will be recruited for or who will participate in the proposed clinical trial. For more information, a Human Subject Resource Document is provided at https://ebrap.org/eBRAP/public/Program.htm.
Research Scope: Research proposed under the FY15 MBRP Burn Injuries Research Award may include small- to large-scale projects such as efficacy studies, effective comparison studies, human use, observational studies, clinical trial development, and clinical trials. These awards are expected to yield potential health products, approaches, or technologies positioned for human testing. Applications may include Phase I or early Phase II clinical trials, but not late Phase II or Phase III, large-scale effectiveness clinical trials or advanced development of products and capabilities. Activities allowed under the FY15 Burn Injuries Research Award may include, but are not limited to:
• Refinement of concepts and ideas into potential solutions with a view toward evaluating technical feasibility of emerging approaches, technologies, and promising new products
• Evaluation, maturation, and/or down-selection of potential product candidates (drugs, biologic/vaccine constructs, or devices/systems) in vitro and/or in vivo
• Conducting preclinical safety and/or toxicity studies
• Preparation activities needed to support a future clinical trial or regulatory submission
• Clinical trials (Phase I or Phase IIa)
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

CDMRP Help Desk

301-682-5507
Email:help@eBRAP.org

Version History

Version Modification Description Updated Date

Folder 277556 Full Announcement-1 -> mbrp_fy15_bira_pa_gg.pdf

Packages

Agency Contact Information: CDMRP Help Desk
301-682-5507
Email: help@eBRAP.org
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
12.420 PKG00217653 Jun 30, 2015 Dec 03, 2015 View

Package 1

Mandatory forms

277556 RR_SF424_2_0-2.0.pdf

277556 RR_Budget_1_3-1.3.pdf

277556 RR_KeyPersonExpanded_2_0-2.0.pdf

277556 PerformanceSite_2_0-2.0.pdf

Optional forms

277556 RR_SubawardBudget30_1_3-1.3.pdf

2025-07-09T13:37:26-05:00

Share This Post, Choose Your Platform!

About the Author: